http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
-
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
-
PracticeLink Reveals Evolved Brand Identity Focused on Clarity, Simplicity and Trust for Healthcare Providers and Recruiters
-
Worksport receives full North American certification for COR energy system
-
Lochbox Technologies, Inc. Is Now Callegra Technologies, Inc.
-
Pineapple Financial Deepens Strategic Relationship with Canary Capital
-
Dalrada Technology Group, Inc. Announces Agreement Supporting Ultra-High Temperature Industrial Heat Pump Development
-
Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
-
PureTech publishes phase 2b trial results for lung fibrosis drug
-
PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine
-
Calvin Choi re-appointed as chief president of Hong Kong youth group
-
Dr. Calvin Choi, Founder of AMTD IDEA, Re‑Appointed as the Chief President of the Hong Kong Island Youth United Association
-
Coupa names Jeff Collier as chief revenue officer
-
Publicis Groupe to acquire sports marketing agency 160over90
-
Max Schireson, Roland Anderson Named Investment Partners at Battery Ventures
-
GALLO Completes Acquisition of Four Roses Bourbon From Kirin Holdings
-
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
-
Coupa Appoints Jeff Collier as Chief Revenue Officer
-
Your yard has secrets: neighbours could pay the price if you don’t click before you dig
-
Publicis Groupe disrupts sports marketing landscape with acquisition of 160over90
-
Publicis Groupe disrupts sports marketing landscape with acquisition of 160over90
-
Safe Launches Safenet Beta, Giving SAFE Token Holders a Role in Network Security
-
Soluna acquires 150 MW wind farm for $53 million in West Texas
-
Soligenix publishes HyBryte study results in Oncology and Therapy
-
Context Therapeutics receives FDA fast track status for ovarian cancer drug
-
Realbotix Closes Sale of Domain Name Portfolio for US$2.245
-
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
-
Soluna Closes $53M Briscoe Wind Farm Acquisition; Achieves Vertical Integration
-
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
-
Seaport Therapeutics reports positive phase 1 results for anxiety drug
-
PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers
-
MAX Power Advances Basin-Scale Discovery Potential with Multi-Zone Natural Hydrogen and Helium Intervals at Bracken
-
Lightbridge to Participate at Upcoming Investor Conferences
-
Merck starts phase 2b/3 trial for eye disease drug MK-8748
-
Merck Announces Initiation of Pivotal Phase 2b/3 Trial Evaluating MK-8748 (Tiespectus), an Investigational Bispecific Tie2 Agonist/VEGF Inhibitor, for the Treatment of Neovascular Age-Related Macular
-
European Commission approves KEYTRUDA plus paclitaxel for ovarian cancer
-
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 (CPS ≥1) Platinum-Resistant Recurrent Ovarian Carcinoma Who Have Receive
-
Kraken Robotics Schedules Q4 and Year-End 2025 Financial Results Release and Webcast
-
Hayasa Metals Announces 39m @ 0.50% Cu from Late Season Drill Hole at Urasar; Prospects Update
-
Sandgarden Acquires Layer, Expanding Engineering Team Behind Doc Holiday
-
Arch Biopartners raises $600,000 in private placement offering
-
Arch Biopartners Closes Non-Brokered Private Placement
-
DeFi Technologies receives cease trade order from Ontario regulator
-
5 Best Altcoin Picks You Can’t Miss: APEMARS Stage 14 Presale Leads As The Best Crypto Presale To Buy Today
-
TotalEnergies and Masdar form $2.2 billion renewable energy joint venture
-
TotalEnergies and Masdar to Form $2.2 Billion Joint Venture to Accelerate Renewable Energy Growth in Asia
-
Early Crypto Presales Could Unlock the Next Opportunity: APEMARS Leads Top 10 Meme Coins 2026
-
MedMira Reports Second Quarter Results FY2025
-
Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi
-
Westport Announces Issuance of Management Cease Trade Order
